# Budesonide Nasal Irrigation Versus Fluticasone Propionate Nasal Spray in Treating Allergic Rhinitis Patients

> **NCT06858423** · PHASE4 · COMPLETED · sponsor: **Benha University** · enrollment: 360 (actual)

## Conditions studied

- Nasal Allergy

## Interventions

- **DRUG:** Budesonide buffered with 0.9% isotonic saline.
- **DRUG:** Fluticasone propionate nasal spray.
- **OTHER:** 0.9% saline for nasal irrigation.

## Key facts

- **NCT ID:** NCT06858423
- **Lead sponsor:** Benha University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-15
- **Primary completion:** 2024-03-31
- **Final completion:** 2024-05-31
- **Target enrollment:** 360 (ACTUAL)
- **Last updated:** 2025-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06858423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06858423, "Budesonide Nasal Irrigation Versus Fluticasone Propionate Nasal Spray in Treating Allergic Rhinitis Patients". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06858423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*